Tag: pharmaceuticals
-
Int’l Group Backs Novavax Covid-19 Vaccine
A global consortium is funding a biotechnology company’s clinical trials and manufacturing plans for a vaccine protecting against Covid-19 viruses.
-
Pharmas License A.I.-Aided Gene Therapies
A university spin-off company designing synthetic viruses with artificial intelligence to deliver gene therapies is licensing its work for eye and muscle disorders.
-
Stem Cell Therapy Licensed for Genetic Eye Disease
A biotechnology company is licensing its stem cell treatments for retinitis pigmentosa, an inherited eye disease, in a deal valued at $252 million.
-
Vaccine Blocks Suspected Type 1 Diabetes Infections
A candidate vaccine is shown in lab animals to produce a strong immune response against a virus causing a range of diseases, and possibly blocking type 1 diabetes.
-
Synthetic Antibody Limits M.S. Inflammation
An artificial antibody is shown in lab mice to reduce inflammation similar to multiple sclerosis in the brain and activate myelin cells in the spinal cord.
-
TB Vaccine Test on Covid-19 Expanding to Europe
A clinical trial testing a current tuberculosis vaccine among health care workers in Australia is expanding in that country and to two European countries.
-
Biotech Gains Antibody Discovery, Manufacturing Funds
A Canadian biotechnology company is receiving government funds for Covid-19 antibody discovery and manufacturing for current and future pandemics.
-
A.I.-Aided Method Predicts Glaucoma Progression
Clinical trial results show a technique visualizing cells in the retina and analyzed with an algorithm accurately predicts the progression of glaucoma.
-
Trial Tests Blood Pressure Drug as Covid-19 Treatment
A common type of blood pressure drug will soon be tested in a clinical trial as a treatment for severe cases of Covid-19 infections.
-
Oxford, AstraZeneca Partner on Covid-19 Vaccine
AstraZeneca agreed today to help develop, manufacture, and distribute a candidate vaccine to prevent Covid-19 infections designed by University of Oxford.